Alvotech (ALVO) Interest Coverage Ratio Growth (3y) (2024 - 2026)
Alvotech (ALVO) Interest Coverage Ratio Growth (3y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.30 Bn | 39.65 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.45 Bn | 29.77 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | -3.69% |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 75.30% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -72.71% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | -2.64% |
| 8 | Elanco Animal Health | 11.70 Bn | 11.17 Bn | 798.00 Mn | 37.62% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Alvotech | 1.23 Bn | 1.23 Bn | 5.09 Mn | -25.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 92.00% |
| Dec 31, 2025 | -50.64% |
| Jun 30, 2025 | 61.07% |
| Mar 31, 2025 | 13.68% |
| Dec 31, 2024 | 57.44% |
| Sep 30, 2024 | -185.21% |